Vertex Advances Kidney Disease Drug into Phase 3 Trial
Key Highlights Inaxaplin enters Phase 3 of its pivotal trial, focusing on AMKD patients, including adolescents aged 10 to…
Browsing Tag
European Medicines Agency (EMA)
2 posts
Kindeva Drug Delivery Acquires Summit Biosciences, Expanding Nasal Drug-Delivery Capabilities
Key Highlights Expanding Drug-Delivery Platforms: Kindeva acquires Summit Biosciences, adding intranasal drug delivery to its diverse capabilities in drug-device…